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Objectives: The outcome for a wide variety of diseases and treatment methods varies by gender. In an effort to determine
whether gender has a role in the outcome of endovascular aortic aneurysm repair, we analyzed data from consecutive
patients treated at a single institution over 6 years.
Methods: Over 6 years ending in March 2002, 704 patients underwent endovascular repair of an infrarenal abdominal
aortic aneurysm at The Cleveland Clinic. Six hundred six patients (86.1%) were men and 98 patients (13.9%) were
women. Preprocedure and postprocedure imaging studies were evaluated to determine the frequency of aneurysm sac
shrinkage or growth, defined as diameter change equal to or greater than 5 mm. Presence and type of endoleak was
assessed with non–contrast material–enhanced, post-contrast-enhanced, and delayed post-contrast-enhanced computed
tomography scans. These and other clinical variables were assessed with the Kaplan-Meier method and the Cox-Mantel
log-rank test, and values were expressed as mean  SE.
Results: Male and female patients were comparable with respect to baseline comorbid conditions. Women, however, were
slightly older (76.7  0.7 years vs 74.4  0.3 years; P  .009), and had slightly smaller aneurysms (5.2  0.1 cm vs 5.4
 0.04 cm; P  .033). There were no gender-specific differences in perioperative mortality (men, 1.3%; women, 3.1%; P
 .197) or mid-term (24 months) survival (men, 80% 2.6%; women, 78% 8.1%). Similarly, there were no differences
at 24 months in risk for graft migration (7.5%  2.0% vs 5.4%  3.2%), need for secondary remedial procedures (24% 
2.9% vs 21%  6.3%), conversion to open surgery (3.9%  1.5% vs 3.8% 2.7%), or post-repair aneurysm rupture (1.1%
 0.9% vs 2.2% 2.2%) in male and female patients, respectively. In contrast, risk for graft limb occlusion at 24 months
was significantly higher in women than in men (11%  5.2% vs 3.3%  1.1%; P  .022). While frequency of endoleak of
any type did not differ among male and female patients, aneurysm sac shrinkage at 24 months was more rapid in women
(76%  8.1% vs 57%  3.5%; P  .019).
Conclusions: With the exception of slightly older age and somewhat smaller aneurysm, female patients are similar to male
patients undergoing endovascular aneurysm repair. A greater frequency of graft limb occlusion was observed in female
patients, but no statistically significant differences were detected in survival, rupture risk, or need for secondary
procedures. Moreover, a more rapid rate of aneurysm sac shrinkage was detected in women. These observations suggest
that endovascular aneurysm repair should be offered to suitable candidates irrespective of gender. (J Vasc Surg 2003;38:
93-8.)
A wide array of diseases are manifested differently in
male and female patients, including both the clinical aspects
of the disease and the results of therapy. Foremost in this
regard are coronary artery disease and coronary artery by-
pass grafting, carotid stenosis and carotid endarterectomy,
and infrainguinal disease and revascularization.1 Abdomi-
nal aortic aneurysm (AAA) is no exception. In large popu-
lation-based studies of patients undergoing open surgical
repair of AAA, the proportion of female patients rarely
exceeds 20%.2,3 Further, some studies have observed atten-
uated survival in females after AAA repair,4,5 but others
series have failed to confirm these findings.3,6
Whether outcome after open surgical aneurysm repair
is gender-specific, certainly the results of endovascular re-
pair may be disparate in male and female patients. While
there is abundant information in the literature demonstrat-
ing gender differences in aortoiliac anatomy,7-9 only a few
reports link these anatomic dissimilarities to clinical out-
come.10,11 Presently available devices are relatively large
and may perform poorly in patients with small access ves-
sels.12 The large multicenter registries rarely include anal-
yses of gender-specific results, and most patients studied are
male.13 Such information is of crucial importance, because
some recent reports suggest that the results of the available
endovascular trials may not be readily translatable to female
patients.11,14 In an effort to determine whether gender has
a role in the outcome of endovascular aortic aneurysm
repair, we analyzed data from a series of consecutive pa-
tients who received treatment at a single institution.
METHODS
Over the 6 years between March 1996 and February
2002, 704 patients underwent endovascular repair of infra-
renal AAA at The Cleveland Clinic. Six hundred six patients
(86%) were men, and 98 patients (14%) were women.
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Patient age ranged from 49 to 100 years (mean SD, 75
8.1 years). The diameter of the aneurysm sac averaged 54
10 mm in minor dimension and 58  11 mm in major
dimension. Primarily, five different devices were used (Ta-
ble I): Ancure (Guidant, Menlo Park, Calif) in 63 patients
(8.9%), AneuRx (Medtronic/AVE, Santa Rosa, Calif) in
203 patients (28.8%), Excluder (W. L. Gore and Associates,
Flagstaff, Ariz) in 25 patients (3.6%), Talent (Medtronic,
Sunrise, Fla) in 39 patients (5.5%), and Zenith (Cook,
Bloomington, Ind) in 333 patients (47.3%). Other miscel-
laneous devices were used with lesser frequency in the
remaining 41 patients (5.8%). Patients underwent preoper-
ative helical computed tomography (CT) with a specified
imaging protocol that included 3 mm axial reconstructions.
Preoperative angiography and intravascular ultrasound
were used when length or diameter measurements were
deemed inaccurate on the basis of the CT scan, in the
presence of suspected renal or iliac occlusive disease, or
when the endograft was placed as part of a clinical trial that
mandated these studies. Three-dimensional CT recon-
structions were rarely obtained. When the endovascular
repair was performed as part of a clinical trial, institutional
review board approval was obtained, and all patients gave
informed consent. When the procedure was performed
with a commercially available device, patient consent was
obtained, and follow-up adhered to the institutional stan-
dard of care, which paralleled most of the clinical trial
protocol. In all cases, postoperative follow-up was rigorous,
with strict attention to timing and quality of imaging
studies. Except in patients with contraindications, eg, renal
insufficiency or history of severe allergy to contrast me-
dium, postoperative CT scans included non-contrast-en-
hanced, contrast-enhanced, and 3-minute to 5-minute de-
layed post-contrast-enhanced images. Follow-up studies
including four-view plain radiographs and triphase CT
scans were obtained at 1, 6, and 12 months and annually
thereafter.
Outcome reporting adhered to the standards outlined
by the Ad Hoc Committee for Standardized Reporting
Practices in Vascular Surgery of The Society for Vascular
Surgery/American Associate for Vascular Surgery (SVS/
AAVS).15 Late deaths were classified as aneurysm-related
or aneurysm-unrelated, where aneurysm-related deaths in-
cluded those that occurred as a result of aneurysm rupture
or within 30 days of any primary or secondary procedure
performed to treat the aneurysm or complications thereof.
Secondary procedures were defined as any procedure, per-
cutaneous or open, performed to treat an endograft-related
problem, performed after the patient left the operating
room at the time of initial endograft implantation. Diag-
nostic procedures were not included as secondary proce-
dures. Examples of secondary procedures included embo-
lization of endoleak, additional cuffs and stents placed
because of migration or endoleak, and open surgical con-
version. Device migration was defined when the proximal
or distal aspect of the device was observed to have migrated
more than 10 mm relative to anatomic landmarks or a lesser
distance that led to symptoms or required therapy.15 An-
eurysm shrinkage or growth was determined on CT scans
obtained 3 months or less before the date of the procedure.
A pre-discharge imaging study was used as the reference
scan when a preoperative study was not available. Graft
migration was determined with the first postoperative scan
as a reference. Size measurements were made on the CT
image, with the greatest minor sac dimension on any axial
image (shorter of two diameters when the sac was ellipti-
cal), generally found on a cut roughly halfway from the
cranial and caudal extent of the aneurysm sac. Aneurysm
shrinkage was defined as decrease of 5 mm or more in the
minor dimension of the sac; enlargement was defined as
increase of 5 mm or more in the minor dimension.
All binary outcome events were analyzed with the
Kaplan-Meier method except for outcome measures, with-
out any censoring, eg, immediate postoperative parame-
ters. Risk at 24 months was specified for all end points
except endoleak, for which 12-month data were substi-
tuted because standard error exceeded 10% at 24 months.
The log-rank test was used to compare differences between
Kaplan-Meier curves. 2 analysis was used to compare
dichotomous variables. Association between baseline vari-
ables, ie, age, gender, aneurysm diameter, iliac angulation,
iliac diameter and length, and brand of device, and aneu-
rysm shrinkage and graft limb occlusion were assessed with
stepwise multiple regression analysis, with P  .10 to
include variables in the model and P  .05 to remove
variables. Values are expressed as mean  SE. P  .05
(two-tailed test) was considered significant.
RESULTS
There was no significant difference in frequency of
baseline medical comorbid conditions between genders.
Female patients, however, were slightly older (76.7  0.7
years vs 74.4  0.3 years; P  .009), had slightly smaller
aneurysms (minor dimension, 5.2  0.1 cm vs 5.4  0.04
cm; P  .033), and had smaller common iliac arteries
(diameter, 14.6 5.9 mm vs 17.5 6.4 mm diameter; P
.024). Among the 704 patients, 30-day mortality rate was
1.6% overall, 1.1% in elective cases, and 15% in urgent
(symptomatic or ruptured) cases. While the point estimate
for perioperative mortality was higher in female patients,
Table I. Gender distribution by brand of device used
Female Male
Totaln % n %
Ancure 14 22 49 78 63
AneuRx 28 14 175 86 203
Excluder 2 8.0 23 92 25
Talent 2 5.1 37 95 39
Zenith 37 11 296 89 333
Other* 15 37 26 63 41
All 98 14 606 86 704
*Endologix (Irvine, Calif), PowerLink (n  2, neither in women), AneuRx
aortomonoiliac (n  6, 3 women). Ancure tube graft (n  10, 3 women).
Zenith aortomonoiliac (n  21, 8 women), homemade (n  2, 1 woman).
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the difference did not attain statistical significance (3.1% vs
1.3%; P  .197). At mid-term (24 months), survival was
similar in the two sexes (80% 2.6% in men, 78% 8.1% in
women; P  .239: Fig 1), as was rate of aneurysm-related
death (3.1%  1.3% in men, 3.1%  1.8% in women; P 
.248).
Limb occlusions were observed more often in women,
occurring in 11% 5.2% vs 3.3% 1.1% at 24 months (P
.022; Fig 2). While there was also higher risk for limb
occlusion when an Ancure device was implanted (odds ratio
[OR], 3.67; P  .02), gender effect was independent of
device brand at multivariable analysis (Table II). There was
no difference in frequency of iliac limb stenting by gender,
and size of the introducer sheaths was similar in women and
men. Iliac conduits were used for introduction of the device
in 11 women (11%) and 17 men (2.8%), a difference that
was highly significant (P  .0004).
Aneurysm rupture was not gender-related, occurring in
3 patients after graft implantation, ie, at 4 months in 1
woman, 7 months in 1 man, and 19 months in 1 man.
Among these, 1 patient had a leaking false aneurysm oppo-
site a renal orifice, possibly from stent erosion; 1 patient had
type III separation of an aortic extender cuff and the main
body; and 1 patient had distal type I endoleak when an iliac
limb pulled out from its attachment site and into the
aneurysm sac. Conversion to open surgical repair was infre-
quent, occurring in 3.9%  1.5% of men and 3.8%  2.7%
of women at 24 months (P  .860). Migration of the
endograft, defined with SVS/AAVS criteria,15 was ob-
served in 7.6%  2.0% of men and 5.4%  3.2% of women
at 24 months of follow-up (P  .649). Secondary proce-
dures were required in a similar percentage of men and
women, 24%  2.9% and 21%  6.3%, respectively, at 24
months (P  .882), despite the higher rate of secondary
revascularization procedures (thrombolysis, thrombec-
tomy, femoral-femoral bypass) because of graft limb occlu-
sion in women.
Endoleak of any variety was observed in 30% 2.4% of
men and 35%  7% of women at 12 months, a difference
that did not attain statistical significance (P .358; Fig 3).
Similarly, there were no significant gender-specific differ-
ences in rate of type II endoleak (P .697), 24% 2.3% in
men and 29%  6.8% in women at 12 months (Fig 4).
Device-related endoleak (type I or III) also occurred in a
comparable number of men and women (P  .218), 5.8%
 1.2% vs 7.9%  3.2% at 12 months, respectively (Fig 5).
There were no gender differences in frequency of type I leak
(2.5%  0.7% in men, 2.8%  2.0% in women at 12
months; P  .604) or type III leak (3.3%  1.0% in men,
5.3%  2.7% in women at 12 months; P  .245) when
analyzed separately.
Despite trends toward an increase in number of en-
doleaks in female patients, aneurysm shrinkage was signifi-
cantly greater when compared with that in male patients
(Fig 6). At 24-month follow-up a reduction of 5 mm or
more in sac diameter was observed in 76%  8.1% of
women, compared with only 57%  3.5% of men (P 
.019). Multivariable analysis of the binary outcome of sac
shrinkage excluded gender differences in smaller sac dimen-
sion (major or minor axis) or advanced age as an explana-
Fig 1. Survival in male and female patients.
Fig 2. Graft limb occlusion in male and female patients.





Gender 0.0749 0.0613 .02
Age 0.008 0.0023 .51
Sac diameter 0.0102 0.0227 .38
Sac length 0.0003 0.0012 .59
Angulation (sac-right iliac) 0.0003 0.0011 .56
Angulation (sac-left iliac) 0.0006 0.0011 .29
Right iliac diameter 0.0027 0.0039 .17
Right iliac length 0.0003 0.0014 .69
Left iliac diameter 0.0030 0.0041 .15
Left iliac length 0.0003 0.0015 .67
Sheath size 0.0060 0.0087 .18
Device 0.0652 0.0544 .02
*Only female gender and type of device (Ancure) were associated with limb
occlusion.
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tion for increased rate of shrinkage in women. Frequency of
sac shrinkage was attenuated with increasing age (OR,
0.994  0.004 per year of incremental age; P  .001).
Moreover, while there were differences in gender distribu-
tion by brand of device (P .0002), these differences were
not correlated with sac shrinkage. Devices associated with
the greatest amount of shrinkage (Talent and Zenith, data
not shown) were less commonly implanted in female pa-
tients. Differences in frequency of aneurysm enlargement
after repair (5 mm or more in sac diameter), while appear-
ing to occur more frequently in men over long-term fol-
low-up (Fig 7), did not approach statistical significance (P
 .769).
DISCUSSION
Eligibility for transfemoral treatment of infrarenal aor-
tic aneurysms depends, in part, on the ability to safely
deliver the endovascular device to its intended target loca-
tion. Thus the procedure relies on both adequate size and
quality of the external and common iliac vessels. Whereas
size of the access vessels is usually acceptable in male
patients, female patients often have smaller iliac arteries,
which may preclude an endovascular option.7-9 The obser-
vation of a lower eligibility rate for women versus men
undergoing screening for endovascular repair of AAA16 is
compounded by gender-bias against repair of aneurysms in
female patients.4,17 While the prevalence of AAA in male to
female patients is approximately 2.5:1, men appear more
likely to undergo open surgical aneurysm repair by a ratio of
almost 2:1,4 accounting for the commonly observed 15% to
20% female proportion of patients undergoing surgical
repair of AAA. The proportion of female patients is even
lower when endovascular repair is undertaken, ranging
below 10% in many series.14,18 We have not observed such
a discrepancy at our institution; women underwent 14% of
Fig 3. Freedom from endoleak of any type in male and female
patients.
Fig 4. Freedom from type II endoleak in male and female patients.
Fig 5. Freedom from device-related endoleak, type I or type III.
Fig 6. Frequency of aneurysm sac shrinkage, expressed as propor-
tion without sac shrinkage of 5 mm or more, in male and female
patients.
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endovascular AAA repairs in the present series and 13% in a
recently reported 10-year open surgical experience.19 Not-
withstanding, previous investigations directed at discerning
outcome differences between male and female patients
receiving endografts have included only 26 women in one
report11 and only 7 women in another.10 These issues
exemplify the dearth of information on gender-specific
outcome and were the motivation behind the current in-
vestigation.
The present series documents important differences in
demographic features of men and women undergoing en-
dovascular repair. Women were older than men, a finding
reported by others.2,10,11 Women had slightly smaller an-
eurysms at repair, another observation previously report-
ed.2,10 Like many studies of open surgical and endovascular
treatment of AAA,10,11,19,20 we were unable to document a
statistically significant increase in mortality among female
patients. Similar to previous studies, however, the number
of female patients in the present study may have compro-
mised detection of a significant difference. Although our
sample size of almost 100 female patients was appreciably
greater than that of previous studies, risk for type II error
remained sizeable.
Complications such as migration, device-related en-
doleak, aneurysm rupture, and need for secondary proce-
dures or open surgical conversion occurred with similar
frequency in male and female patients. Limb occlusion,
however, was observed with significantly higher frequency
in women. While this finding may be related to the smaller
size of access arteries and associated risk for traumatic
dissection, multivariate analysis did not identify iliac diam-
eter as an independent risk factor for limb occlusion. As
well, the cumulative incidence of limb occlusion continues
to diverge after the first year, suggesting that factors other
than acute dissection-induced thrombotic occlusion may
be important. Progressive intimal hyperplasia at the site of
vascular injury sustained at the time of implantation, differ-
ences in gender-related thrombotic tendencies, or another
cause may explain these late findings. The observed reduc-
tion in patency of endograft limbs is reminiscent of the
observation of reduced infrainguinal graft patency in wom-
en.1,21
In the EUROSTAR experience, endoleak was 1.7 times
more likely to develop in women compared with men after
endovascular AAA repair.18 Although we did not evaluate
proximal aortic neck length in this study, other series have
noted a shorter proximal aortic neck length in women.10,11
While we did not observe a statistically significant increase
in rate of endoleak in women, the point estimate trended
higher in female patients for types I, II, and III endoleak.
Surprisingly, this trend did not translate into a reduced rate
of aneurysm sac shrinkage. Rate of shrinkage was signifi-
cantly greater in female patients than in male patients, a
finding unique to the present series. Multivariate analysis
did not demonstrate that increased shrinkage was a result of
gender difference in baseline sac diameter or patient age.
Consequently, increased rate of sac shrinkage in female
patients remains unexplained, and the observation warrants
additional study.
In summary, women comprise a small minority of
patients undergoing endovascular aneurysm repair.
Women undergoing endovascular AAA repair are slightly
older and their aneurysms are smaller when compared with
men. Although overall results are similar to those observed
among men, problems with access requiring iliac conduits
and a higher risk for early and late graft limb thrombosis
should be anticipated in women undergoing endovascular
aneurysm repair. Most important, however, are the obser-
vations that similar perioperative mortality and long-term
survival, as well as more rapid aneurysm sac shrinkage, in
women suggest that endovascular treatment of AAA should
be offered to suitable candidates irrespective of gender.
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